 Mary Margaret Chren, MD
|
|
| Title | Professor |
|---|
| School | UCSF School of Medicine |
|---|
| Department | Dermatology |
|---|
| Address | 2340 Sutter Street
San Francisco CA 94143
|
|---|
| Phone | 415-476-9757 |
|---|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Mihalis EL, Wysong A, Boscardin WJ, Tang JY, Chren MM, Arron ST. Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients. Br J Dermatol. 2013 Feb; 168(2):346-53.
-
Hausauer AK, Maurer T, Leslie KS, Parvataneni R, Stuart SE, Chren MM. Recurrence after treatment of cutaneous Basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus. JAMA Dermatol. 2013 Feb 1; 149(2):239-41.
-
Chren MM, Linos E, Torres JS, Stuart SE, Parvataneni R, Boscardin WJ. Tumor recurrence 5 years after treatment of cutaneous Basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2013 May; 133(5):1188-96.
-
Paller AS, Chren MM. Out of the skin of babes: measuring the full impact of atopic dermatitis in infants and young children. J Invest Dermatol. 2012 Nov; 132(11):2494-6.
-
Gogia R, Binstock M, Hirose R, Boscardin WJ, Chren MM, Arron ST. Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol. 2013 Apr; 68(4):585-91.
-
Wehner MR, Shive ML, Chren MM, Han J, Qureshi AA, Linos E. Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ. 2012; 345:e5909.
-
Vasquez R, Wang D, Tran QP, Adams-Huet B, Chren MM, Costner MI, Cohen JB, Werth VP, Chong BF. A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus. Br J Dermatol. 2013 Jan; 168(1):145-53.
-
Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012 Apr; 30(2):231-6, xiii.
-
Asgari MM, Warton EM, Neugebauer R, Chren MM. Predictors of patient satisfaction with Mohs surgery: analysis of preoperative, intraoperative, and postoperative factors in a prospective cohort. Arch Dermatol. 2011 Dec; 147(12):1387-94.
-
Chren MM. The contribution of health services research to improved dermatologic care. J Invest Dermatol. 2012 Mar; 132(3 Pt 2):1003-7.
-
Linos E, Keiser E, Kanzler M, Sainani KL, Lee W, Vittinghoff E, Chren MM, Tang JY. Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006. Cancer Causes Control. 2012 Jan; 23(1):133-40.
-
Tan J, Wolfe B, Weiss J, Stein-Gold L, Bikowski J, Del Rosso J, Webster GF, Lucky A, Thiboutot D, Wilkin J, Leyden J, Chren MM. Acne severity grading: determining essential clinical components and features using a Delphi consensus. J Am Acad Dermatol. 2012 Aug; 67(2):187-93.
-
Chua SL, Maurer T, Chren MM. Adaptation of a Runyankore version of Skindex-16 for oral administration in Mbarara, Uganda. Int J Dermatol. 2011 Oct; 50(10):1249-54.
-
Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2011 Dec; 65(6):1145-51.
-
Mehta KM, Pierluissi E, Boscardin WJ, Kirby KA, Walter LC, Chren MM, Palmer RM, Counsell SR, Landefeld CS. A clinical index to stratify hospitalized older adults according to risk for new-onset disability. J Am Geriatr Soc. 2011 Jul; 59(7):1206-16.
-
Chren MM, Torres JS, Stuart SE, Bertenthal D, Labrador RJ, Boscardin WJ. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol. 2011 May; 147(5):540-6.
-
Klein R, Moghadam-Kia S, Taylor L, Coley C, Okawa J, LoMonico J, Chren MM, Werth VP. Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol. 2011 May; 64(5):849-58.
-
Asgari MM, White E, Warton EM, Hararah MK, Friedman GD, Chren MM. Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer. 2011; 63(2):314-8.
-
Chamlin SL, Chren MM. Quality-of-life outcomes and measurement in childhood atopic dermatitis. Immunol Allergy Clin North Am. 2010 Aug; 30(3):281-8.
-
Chren MM. Interpretation of quality-of-life scores. J Invest Dermatol. 2010 May; 130(5):1207-9.
-
Tang JY, Parimi N, Wu A, Boscardin WJ, Shikany JM, Chren MM, Cummings SR, Epstein EH, Bauer DC. Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. Cancer Causes Control. 2010 Mar; 21(3):387-91.
-
Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol. 2010 Apr; 146(4):388-95.
-
Asgari MM, Tang J, Warton ME, Chren MM, Quesenberry CP, Bikle D, Horst RL, Orentreich N, Vogelman JH, Friedman GD. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol. 2010 May; 130(5):1438-43.
-
Asgari MM, Tang J, Epstein EH, Chren MM, Warton EM, Quesenberry CP, Go AS, Friedman GD. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
-
Asgari MM, Bertenthal D, Sen S, Sahay A, Chren MM. Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg. 2009 Jul; 35(7):1041-9.
-
Weinstock MA, Lee KC, Chren MM, Marcolivio K. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial. J Am Acad Dermatol. 2009 Aug; 61(2):207-15.
-
Ponte M, Klemperer E, Sahay A, Chren MM. Effects of vulvodynia on quality of life. J Am Acad Dermatol. 2009 Jan; 60(1):70-6.
-
Clark FL, Sahay A, Bertenthal D, Maddock L, Lindquist K, Grekin R, Chren MM. Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic. Arch Dermatol. 2008 Sep; 144(9):1148-52.
-
VanBeek M, Beach S, Braslow L, Braslow JB, Chen SC, Chren MM, Margolis D, Chamlin S, Torrance G, Hodgson T. Highlights from the report of the working group on "Core measures of the burden of skin diseases". J Invest Dermatol. 2007 Dec; 127(12):2701-6.
-
Chen T, Bertenthal D, Sahay A, Sen S, Chren MM. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol. 2007 Nov; 143(11):1386-92.
-
Chamlin SL, Lai JS, Cella D, Frieden IJ, Williams ML, Mancini AJ, Chren MM. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol. 2007 Jun; 143(6):768-72.
-
Steinman MA, Chren MM, Landefeld CS. What's in a name? Use of brand versus generic drug names in United States outpatient practice. J Gen Intern Med. 2007 May; 22(5):645-8.
-
Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007 Aug; 57(2):213-21.
-
Aksu AE, Urer MS, Sabuncu I, Saracoglu ZN, Chren MM. Turkish version of Skindex-29. Int J Dermatol. 2007 Apr; 46(4):350-5.
-
Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA. Characteristics and impact of drug detailing for gabapentin. PLoS Med. 2007 Apr; 4(4):e134.
-
Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2007 Jun; 127(6):1351-7.
-
Jones-Caballero M, Chren MM, Soler B, Pedrosa E, Peñas PF. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol. 2007 Feb; 21(2):219-26.
-
Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006 Aug 15; 145(4):284-93.
-
Nijsten TE, Sampogna F, Chren MM, Abeni DD. Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol. 2006 Jun; 126(6):1244-50.
-
Chren MM. Determining the value of surgical therapies for basal cell carcinoma. Arch Dermatol. 2006 Feb; 142(2):231-2.
-
Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006 Feb; 154(2):325-31.
-
O'Hare AM, Bertenthal D, Sidawy AN, Shlipak MG, Sen S, Chren MM. Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease. Clin J Am Soc Nephrol. 2006 Mar; 1(2):297-304.
-
Chamlin SL, Cella D, Frieden IJ, Williams ML, Mancini AJ, Lai JS, Chren MM. Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol. 2005 Dec; 125(6):1106-11.
-
Chren MM. Measurement of vital signs for skin diseases. J Invest Dermatol. 2005 Oct; 125(4):viii-ix.
-
Gupta MA, Johnson AM, Chren MM. Evaluating clinical rating scales for evidence-based dermatology: some basic concepts. Dermatol Clin. 2005 Oct; 23(4):703-6.
-
Chamlin SL, Mattson CL, Frieden IJ, Williams ML, Mancini AJ, Cella D, Chren MM. The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med. 2005 Aug; 159(8):745-50.
-
O'Hare AM, Bertenthal D, Shlipak MG, Sen S, Chren MM. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol. 2005 Feb; 16(2):514-9.
-
Asgari M, White E, Chren MM. Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg. 2004 Oct; 30(10):1335-42.
-
Chren MM, Sahay AP, Sands LP, Maddock L, Lindquist K, Bertenthal D, Bacchetti P. Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic. Med Care. 2004 Oct; 42(10):1019-26.
-
Chamlin SL, Frieden IJ, Williams ML, Chren MM. Effects of atopic dermatitis on young American children and their families. Pediatrics. 2004 Sep; 114(3):607-11.
-
Shapiro M, Chren MM, Levy RM, Elder DE, LeBoit PE, Mihm MC, Margolis DJ, Gimotty PA, Ming ME. Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol. 2004 Sep; 31(8):523-30.
-
Sampogna F, Picardi A, Chren MM, Melchi CF, Pasquini P, Masini C, Abeni D. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004 Jul-Aug; 66(4):620-4.
-
Chren MM, Weinstock MA. Conceptual issues in measuring the burden of skin diseases. J Investig Dermatol Symp Proc. 2004 Mar; 9(2):97-100.
-
Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, Feldman SR, Chren MM. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003 Sep; 149(3):572-7.
-
Sands LP, Yaffe K, Covinsky K, Chren MM, Counsell S, Palmer R, Fortinsky R, Landefeld CS. Cognitive screening predicts magnitude of functional recovery from admission to 3 months after discharge in hospitalized elders. J Gerontol A Biol Sci Med Sci. 2003 Jan; 58(1):37-45.
-
Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren MM. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol. 2002 Nov; 29(11):693-8.
-
Chen SC, Yeung J, Chren MM. Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dermatol. 2002 Jun; 138(6):803-7.
-
Chren MM. Doctor's orders: rethinking compliance in dermatology. Arch Dermatol. 2002 Mar; 138(3):393-4.
-
Pine ZM, Gurland B, Chren MM. Use of a cane for ambulation: marker and mitigator of impairment in older people who report no difficulty walking. J Am Geriatr Soc. 2002 Feb; 50(2):263-8.
-
Mirmirani P, Maurer TA, Berger TG, Sands LP, Chren MM. Skin-related quality of life in HIV-infected patients on highly active antiretroviral therapy. J Cutan Med Surg. 2002 Jan-Feb; 6(1):10-5.
-
Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology. 2002; 204(1):43-9.
-
Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol. 2001 May; 144(5):1038-43.
-
Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001 Mar-Apr; 5(2):105-10.
-
Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR, Elias PM. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol. 2001 Jan; 137(1):53-9.
-
Jones-Caballero M, Peñas PF, García-Díez A, Badía X, Chren MM. The Spanish version of Skindex-29. Int J Dermatol. 2000 Dec; 39(12):907-12.
-
Pine ZM, Gurland B, Chren MM. Report of having slowed down: evidence for the validity of a new way to inquire about mild disability in elders. J Gerontol A Biol Sci Med Sci. 2000 Jul; 55(7):M378-83.
-
Chren MM. Giving "scale" new meaning in dermatology: measurement matters. Arch Dermatol. 2000 Jun; 136(6):788-90.
-
Covinsky KE, Chren MM, Harper DL, Way LE, Rosenthal GE. Differences in patient-reported processes and outcomes between men and women with myocardial infarction. J Gen Intern Med. 2000 Mar; 15(3):169-74.
-
Covinsky KE, Palmer RM, Counsell SR, Pine ZM, Walter LC, Chren MM. Functional status before hospitalization in acutely ill older adults: validity and clinical importance of retrospective reports. J Am Geriatr Soc. 2000 Feb; 48(2):164-9.
-
Chren MM. Understanding research about quality of life and other health outcomes. J Cutan Med Surg. 1999 Oct; 3(6):312-6.
-
Chren MM. Interactions between physicians and drug company representatives. Am J Med. 1999 Aug; 107(2):182-3.
-
Sobecks NW, Justice AC, Hinze S, Chirayath HT, Lasek RJ, Chren MM, Aucott J, Juknialis B, Fortinsky R, Youngner S, Landefeld CS. When doctors marry doctors: a survey exploring the professional and family lives of young physicians. Ann Intern Med. 1999 Feb 16; 130(4 Pt 1):312-9.
-
Landefeld CS, Chren MM. Preventing disability in older people with chronic disease: what is a doctor to do? J Am Geriatr Soc. 1998 Oct; 46(10):1314-6.
-
Polster AM, Lasek RJ, Quinn LM, Chren MM. Reports by patients and dermatologists of skin cancer preventive services provided in dermatology offices. Arch Dermatol. 1998 Sep; 134(9):1095-8.
-
Rosenthal GE, Chren MM, Lasek RJ, Landefeld CS. What patients should ask of consumers' guides to health care quality. Eval Health Prof. 1998 Sep; 21(3):316-31.
-
Covinsky KE, Rosenthal GE, Chren MM, Justice AC, Fortinsky RH, Palmer RM, Landefeld CS. The relation between health status changes and patient satisfaction in older hospitalized medical patients. J Gen Intern Med. 1998 Apr; 13(4):223-9.
-
Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998 Apr; 134(4):454-8.
-
Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997 Nov; 133(11):1433-40.
-
Chren MM. Quality of care in dermatology. The state of (measuring) the art. Arch Dermatol. 1997 Nov; 133(11):1349-51.
-
Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol. 1997 Jan; 108(1):103-7.
-
Beyth RJ, Antani MR, Covinsky KE, Miller DG, Chren MM, Quinn LM, Landefeld CS. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med. 1996 Dec; 11(12):721-8.
-
Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996 Nov; 107(5):707-13.
-
Landefeld CS, Chren MM. Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view. J Gen Intern Med. 1996 Oct; 11(10):642-4.
-
Wood GS, Lynch WS, Davis B, Chren MM, Baud E, Brodell RT, Elewski BE, Martin RW, Cooper KD. Restructuring dermatology education at Cleveland medical centers affiliated with Case Western Reserve University. Arch Dermatol. 1996 Sep; 132(9):1085-90.
-
Brodell RT, Wile MZ, Chren MM, Bickers DR. Learning and teaching in dermatology. A practitioner's guide. Arch Dermatol. 1996 Aug; 132(8):946-52.
-
Rosenthal GE, Chren MM, Lasek RJ, Landefeld CS. The annual guide to "America's best hospitals". Evidence of influence among health care leaders. J Gen Intern Med. 1996 Jun; 11(6):366-9.
-
Durden FM, Variyam E, Chren MM. Fat necrosis with features of erythema nodosum in a patient with metastatic pancreatic carcinoma. Int J Dermatol. 1996 Jan; 35(1):39-41.
-
Dong JA, Chren MM, Elewski BE. Bonsai tree: risk factor for disseminated sporotrichosis. J Am Acad Dermatol. 1995 Nov; 33(5 Pt 1):839-40.
-
Chren MM. Dermatologic health services research. Dermatol Clin. 1995 Jul; 13(3):689-95.
-
Chren MM, Lazarus HM, Salata RA, Landefeld CS. Cultures of skin biopsy tissue from immunocompromised patients with cancer and rashes. Arch Dermatol. 1995 May; 131(5):552-5.
-
Chren MM, Landefeld CS. A cost analysis of topical drug regimens for dermatophyte infections. JAMA. 1994 Dec 28; 272(24):1922-5.
-
Chren MM. Costs of therapy for dermatophyte infections. J Am Acad Dermatol. 1994 Sep; 31(3 Pt 2):S103-6.
-
Chren MM. Dermatologic consultations--how can we know if we are effective? Initial methodologic considerations for the critical assessment of medical interventions performed by physicians. Arch Dermatol. 1994 Aug; 130(8):1052-4.
-
Chren MM. Independent investigators and for-profit companies. Guidelines for biomedical scientists considering funding by industry. Arch Dermatol. 1994 Apr; 130(4):432-7.
-
Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994 Mar 2; 271(9):684-9.
-
Casserly CM, Stange KC, Chren MM. Severe megaloblastic anemia in a patient receiving low-dose methotrexate for psoriasis. J Am Acad Dermatol. 1993 Sep; 29(3):477-80.
-
Chren MM, Lazarus HM, Bickers DR, Landefeld CS. Rashes in immunocompromised cancer patients. The diagnostic yield of skin biopsy and its effects on therapy. Arch Dermatol. 1993 Feb; 129(2):175-81.
-
Chren MM. Industry-funded dermatologic research within academia in the United States: fiscal and ethical considerations. J Invest Dermatol. 1992 Nov; 99(5):664-5.
-
Chren MM, Landefeld CS. Doctors, drug companies and gifts. R I Med J. 1991 Dec; 74(12):603-10.
-
Chren MM, Landefeld CS, Murray TH. Doctors, drug companies, and gifts. JAMA. 1989 Dec 22-29; 262(24):3448-51.
-
Chren MM, Silverman RA, Sorensen RU, Elmets CA. Leukocytoclastic vasculitis in a patient infected with human immunodeficiency virus. J Am Acad Dermatol. 1989 Nov; 21(5 Pt 2):1161-4.
-
Landefeld CS, Chren MM, Myers A, Geller R, Robbins S, Goldman L. Diagnostic yield of the autopsy in a university hospital and a community hospital. N Engl J Med. 1988 May 12; 318(19):1249-54.
-
Landefeld CS, Chren MM, Shega J, Speroff T, McGuire E. Students' sexual behavior, knowledge, and attitudes relating to the acquired immunodeficiency syndrome. J Gen Intern Med. 1988 Mar-Apr; 3(2):161-5.
|
Mary Margaret's Networks
Click the "See All" links for more information and interactive visualizations!
Related Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share similar concepts with this person. _
|
